Design Therapeutics
DSGN
11.38
-0.31
-2.65%
Design Therapeutics
US · DSGN
#3479 by market cap
Listed 2021
11.38
-0.31
-2.65%
Live - 5344 symbols - heartbeat 207s ago
· 2026-10-08 09:56
Pre-market
11.81
+1.03%
After-hours
11.69
0.00%
- Market cap
- 712.18M
- P/E (TTM)i
- -9.64
- P/Bi
- 3.53
- EPSi
- -1.22
- Div yieldi
- 0.00%
- 52W posi
- 51%
Reader sentiment
Are you bullish or bearish on DSGN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership fell 1.0 percentage points.
Institutional ownership
- Held by institutions
- 96.22% -1.01pp
- Institutions
- 170 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund32.80%
Hedge Fund30.01%
VC/PE Fund18.12%
Individual/Insider14.08%
Private Company12.47%
Public Company2.25%
Government Pension Fund0.29%
Insurance Company0.16%
Family Office/Trust0.12%
Top holders as of 2026-03-31
Aseem Ansari
12.25% · 7.67M sh
SR One Capital Management, LP
10.43% · 6.53M sh
Sirenia Capital Management LP
8.71% · 5.45M sh
Light Irrevocable Trusts
6.13% · 3.83M sh
Star Irrevocable Trust
6.13% · 3.83M sh
Quan Management LLC
5.41% · 3.38M sh
Logos Global Management, L.P.
4.79% · 3.00M sh
Baker Bros. Advisors LP
4.28% · 2.68M sh
Driehaus Capital Management LLC
4.25% · 2.66M sh
BlackRock
4.25% · 2.66M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
45 filings tracked · 37 buys · 6 sells
| Name | Role | Stake |
|---|---|---|
| Aseem Ansari | Co-Founder & Scientific Advisor | 12.25% |
| SR One Capital Management, LP | -- | 10.43% |
| Sean Jeffries | Chief Operating Officer | 1.31% |
| Rodney Lappe | Independent Director | 0.21% |
| Pratik Shah | Co-Founder, President, CEO, Principal Financial Officer & Executive Chairperson | 0.21% |
| John Schmid | Independent Director | 0.09% |
| Heather Berger | Independent Director | 0.00% |
| Justin Gover | Director | -- |
| David Shapiro | Independent Director | -- |
| Simeon George | Lead Independent Director | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-06-08 | John Schmid | Independent Director | Other Derivative Acquisition | +30,000 | $10.55 |
| 2026-06-08 | Justin Gover | Director | Other Derivative Acquisition | +30,000 | $10.55 |
| 2026-06-08 | David Shapiro | Independent Director | Other Derivative Acquisition | +30,000 | $10.55 |
| 2026-06-08 | Rodney Lappe | Independent Director | Other Derivative Acquisition | +30,000 | $10.55 |
| 2026-06-08 | Simeon George | Lead Independent Director | Other Derivative Acquisition | +30,000 | $10.55 |
| 2026-06-08 | Heather Berger | Independent Director | Other Derivative Acquisition | +30,000 | $10.55 |
| 2026-03-30 | David Shapiro | Independent Director | Other Derivative Acquisition | +67,500 | $10.64 |
| 2026-01-01 | Pratik Shah | Co-Founder, President, CEO, Principal Financial Officer & Executive Chairperson | Other Derivative Acquisition | +750,000 | $9.10 |
| 2026-01-01 | Justin Gover | Director | Other Derivative Acquisition | +45,000 | $9.10 |
| 2026-01-01 | Chris Storgard | Chief Medical Officer | Other Derivative Acquisition | +250,000 | $9.10 |
| 2026-01-01 | Sean Jeffries | Chief Operating Officer | Other Derivative Acquisition | +375,000 | $9.10 |
| 2026-01-01 | Julie Burgess | Chief Accounting Officer | Other Derivative Acquisition | +150,000 | $9.10 |
| 2025-12-08 | Pratik Shah | Co-Founder, President, CEO, Principal Financial Officer & Executive Chairperson | Other Derivative Acquisition | +1,050,000 | $2.48 |
| 2025-11-17 | Logos Global Management, L.P. | -- | Intent to Sell (Form 144) | -120,000 | $7.43 |
| 2025-11-13 | Logos Global Management, L.P. | -- | Intent to Sell (Form 144) | -620,000 | $7.06 |
| 2025-11-06 | Logos Global Management, L.P. | -- | Intent to Sell (Form 144) | -415,000 | $6.87 |
| 2025-09-08 | Justin Gover | Director | Other Derivative Acquisition | +45,833 | $6.64 |
| 2025-08-12 | Logos Global Management, L.P. | -- | Open Market Disposition | -562,627 | $5.25 |
| 2025-06-09 | John Schmid | Independent Director | Other Derivative Acquisition | +19,000 | $4.01 |
| 2025-06-09 | Rodney Lappe | Independent Director | Other Derivative Acquisition | +19,000 | $4.01 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 09:56:28 · For reference only, not investment advice and not tailored to your situation.